WeedMarketCap
Legal MapCommunity
WeedMarketCap

Cannabis market data, tracked daily.

Legal States Map 2026CommunityAboutContactPrivacy Policy

Prices may be delayed. This site is for informational purposes only and does not constitute financial advice. Cannabis stocks carry significant risk — always do your own research.

© 2026 WeedMarketCap. All rights reserved.

WeedMarketCap
Legal MapCommunity
Back to market table
CRLBF logo

Unranked

Cresco Labs Inc.

CRLBF · OTCQX

$0.7829

+5.65% (24h)

Last updated: 1 second ago

Market Cap

$291.51M

Volume (24h)

92.88K

Last Close (7D)

$0.78

View on TradingView
Earnings Nov 5 · in 62d

Company Profile

Exchange
OTCQX
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,900
Website
www.crescolabs.com
Country
🇺🇸 United States

One of the US's largest cannabis companies, Cresco is a wholesale powerhouse that puts its branded products on shelves at competitors' stores — not just its own Sunnyside dispensaries.

  • 📦 Wholesale-first model means Cresco flower and extracts appear in dispensaries it doesn't own
  • 🥇 #1 wholesale cannabis market share in Illinois, its highly competitive home state
  • 🏪 Sunnyside dispensary chain gives Cresco a direct-to-consumer retail channel in key markets

Key Stats

52-Week Range
$0.59$2.30
Beta1.77
Trailing P/EN/A
Forward P/E-18.29
Trailing EPS-0.28
Avg Volume

Earnings & Analyst

Next Earnings2026-11-05
EPS Estimate-0.03
Target Mean Price$2.00
RecommendationNone
Recommendation MeanN/A

Recent SEC Filings

All filings
  • Foreign current report

    Foreign current report filed on 2026-05-08 (6-K).

    6-K

    2026-05-08

    SEC

  • Foreign current report

    Foreign current report filed on 2026-02-02 (6-K).

    6-K

    2026-02-02

    SEC

  • Foreign current report

    Foreign current report filed on 2025-11-07 (6-K).

    6-K

    2025-11-07

Frequently Asked Questions

What does Cresco Labs (CRLBF) do?

Cresco Labs is one of the largest cannabis companies in the United States, operating as a multi-state operator (MSO). The company focuses on cultivating, manufacturing, and distributing cannabis products under its own brands. Its wholesale-first model means that Cresco's flower, extracts, and other products are sold in dispensaries owned by other retailers, not just its own stores. This approach allows Cresco to achieve broad market penetration. In addition to wholesale, the company operates the Sunnyside dispensary chain, which provides a direct-to-consumer retail channel in key markets. Cresco is particularly dominant in Illinois, where it holds the number one wholesale cannabis market share in a highly competitive environment.

What is Cresco Labs' business model?

Cresco Labs employs a wholesale-first business model, meaning its primary focus is on producing cannabis products and selling them to other dispensaries. This strategy allows Cresco to place its branded flower and extracts on shelves at competitors' stores, maximizing distribution without the capital expense of building a large retail footprint. The company also operates its own Sunnyside dispensary chain, which serves as a direct-to-consumer channel in key markets. This dual approach—wholesale dominance supplemented by retail—enables Cresco to capture both upstream and downstream margins. By prioritizing wholesale, Cresco can leverage scale in cultivation and manufacturing, making it a powerhouse in the US cannabis industry.

In which markets does Cresco Labs operate?

Cresco Labs operates primarily in the United States, with a strong presence in Illinois, its home state. Illinois is a highly competitive cannabis market, and Cresco holds the number one wholesale market share there. The company's wholesale distribution network extends to multiple states where cannabis is legal, though specific states beyond Illinois are not detailed in the available data. Additionally, Cresco's Sunnyside dispensary chain provides retail access in key markets, allowing the company to serve consumers directly. As a multi-state operator, Cresco is positioned to benefit from the expanding legal cannabis landscape across the US.

What is Cresco Labs' role in the cannabis sector?

Cresco Labs is classified as a US multi-state cannabis operator (MSO), a category that includes companies licensed to cultivate, process, and sell cannabis across multiple states where it is legal. MSOs like Cresco are central to the US cannabis industry, as they navigate varying state regulations and build scale. Cresco stands out as a wholesale powerhouse, meaning it prioritizes supplying products to other retailers rather than relying solely on its own stores. This role makes it a key player in the supply chain, influencing product availability and brand presence in dispensaries nationwide. Its number one wholesale market share in Illinois further solidifies its leadership within the MSO segment.

What are Cresco Labs' notable brands or differentiators?

Cresco Labs' most notable differentiator is its wholesale-first model, which sets it apart from many MSOs that focus on vertical integration through their own retail stores. By placing its branded flower and extracts in competitors' dispensaries, Cresco achieves widespread distribution and brand recognition. The company's Sunnyside dispensary chain is another key asset, providing a direct retail channel in important markets. In Illinois, Cresco holds the number one wholesale cannabis market share, demonstrating its competitive strength in a crowded state. These factors—wholesale dominance, a strong retail brand, and market leadership in Illinois—make Cresco a distinctive and influential operator in the US cannabis industry.

Latest News

  • SeekingAlpha · Aug 6, 2026

    Cresco Labs Inc. (CRLBF) Q2 2026 Earnings Call Transcript

  • SeekingAlpha · Aug 6, 2026

    Cresco Labs Inc. 2026 Q2 - Results - Earnings Call Presentation

  • Yahoo · Aug 6, 2026

    Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates

  • Yahoo · Aug 6, 2026

    Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA

478.41K
Enterprise Value$739.79M
Shares Outstanding355.59M

SEC

  • Foreign current report

    Foreign current report filed on 2025-09-22 (6-K).

    6-K

    2025-09-22

    SEC

  • Foreign current report

    Foreign current report filed on 2025-09-17 (6-K).

    6-K

    2025-09-17

    SEC

  • Foreign current report

    Foreign current report filed on 2025-08-15 (6-K).

    6-K

    2025-08-15

    SEC

  • Foreign current report

    Foreign current report filed on 2025-08-07 (6-K).

    6-K

    2025-08-07

    SEC

  • Foreign current report

    Foreign current report filed on 2025-06-13 (6-K).

    6-K

    2025-06-13

    SEC

  • Foreign current report

    Foreign current report filed on 2025-05-30 (6-K).

    6-K

    2025-05-30

    SEC

  • Foreign current report

    Foreign current report filed on 2025-03-12 (6-K).

    6-K

    2025-03-12

    SEC